Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The specific aim of this study is to determine the accuracy of Optical Coherence Tomography (OCT) imaging for screening and diagnosis of the distal esophagus in patients undergoing a clinical esophagogastroduodenoscopy (EGD) procedure. The accuracy of results obtained using the developed OCT imaging probe will be determined and compared with those obtained through the traditional standard of care endoscopic biopsy .
| Condition | Intervention | Phase |
|---|---|---|
|
Barrett's Esophagus |
Device: optical frequency domain imaging (OFDI) system |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Optical Coherence Tomography Based Screening and Surveillance of Esophagus and Gastroesophageal Junction |
- Sensitivity and specificity of OFDI imaging [ Time Frame: Images will be acquired during the OFDI imaging session which should take an average of 5 minutes ] [ Designated as safety issue: No ]Images will be analyzed and compared to standard of care biopsy
| Estimated Enrollment: | 300 |
| Study Start Date: | September 2006 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: OFDI imaging
OFDI imaging
|
Device: optical frequency domain imaging (OFDI) system
Imaging of esophagus with OFDI system
|
Detailed Description:
Three hundred consenting patients undergoing routine esophagogastroduodenoscopy (EGD) procedures will be recruited for examination at the gastroesophageal junction with our developed OCT imaging system. The patients will undergo a clinical EGD procedure including endoscopic biopsy. The first step in the procedure follows the standard care with the performance of the surveillance endoscopy. The study experimental procedure will then begin. This study requires the use of a balloon . The balloon placement method is in accordance with current standard clinical practice and involves the insertion of a guide wire through the auxiliary channel of the endoscope. The endoscope is then removed, leaving the guide wire in place, and the OCT balloon is inserted the required distance (determined during the endoscopy) over the guide wire to the GE junction. The OCT balloon will then be inflated and will remain in this fixed position throughout the entire procedure. Once the OCT imaging probe is in place, OCT image data will be continuously collected over the length of the balloon(approximately 5 cm).
It is expected that the total examination time including insertion and inflation of the OCT balloon, OCT imaging and removal of the OCT balloon will add no more than 10 minutes to the total length of the EGD.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- over the age of 18,
- capable of giving informed consent,
- are undergoing elective EGD, and
- if female are willing to take a pregnancy test
Exclusion Criteria:
- patients on oral anticoagulation medications,
- with a history of hemostasis disorders and
- patients that are pregnant
Contacts and Locations| Contact: Guillermo Tearney, MD PhD | 617-724-2979 | gtearney@partners.org |
| Contact: Mireille Rosenberg, PhD | 617-726-9145 | mrosenberg@partners.org |
| United States, Massachusetts | |
| Massachussetts General Hospital | Recruiting |
| Boston, Massachusetts, United States, 02114 | |
| Contact: Norman Nishioka, MD 617-726-4422 nnishioka@partners.org | |
| Principal Investigator: | Guillermo Tearney, MD PhD | Massachussetts General Hospital |
| Principal Investigator: | Norman Nishioka, MD | Massachussetts General Hospital |
More Information
No publications provided
| Responsible Party: | Guillermo Tearney, Professor of Pathology, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT01401699 History of Changes |
| Other Study ID Numbers: | 2006-P-000203, 5R21CA141884 |
| Study First Received: | July 20, 2011 |
| Last Updated: | February 26, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Massachusetts General Hospital:
|
Barrett's esophagus OCT imaging |
Additional relevant MeSH terms:
|
Barrett Esophagus Digestive System Abnormalities Digestive System Diseases Esophageal Diseases Gastrointestinal Diseases |
ClinicalTrials.gov processed this record on May 21, 2013